Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eosinophil-guided Corticosteroid Therapy in AECOPD
NCT02857842Phase 4Completed
- Sponsor
- COPD360Net
- Start
- Aug 2016
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisolone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by COPD360Net. Primary endpoint: Days alive and out of hospital within 14 days after recruitment. Started Aug 2016; status: completed.
02
Drugs
prednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02857842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857842.